Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight

The moderate-to-severe acute pain market size in the 7MM is expected to increase throughout the forecast period (2025–2034), driven by the launch of emerging therapies such as RizaFilm (rizatriptan), CPL-01, PRF-110, OCS-01, F14 (mdc-CWM), NTM-001, Cebranopadol, and others, the growing…